The importance of targeting proliferating and quiescent cells in CLL
Inside the German CLL Study Group's annual workshop
Looking beyond the leukemic cell for answers
Christopher Pepper et al.
Enhancing immunotherapy for CLL patients with ibrutinib
Enhancing autologous cellular therapy with ibrutinib in CLL patients
Iris de Weerdt